Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Thyroid Cancer, Papillary 15Neuroendocrine Tumors 13Carcinoma, Neuroendocrine 10Pituitary Neoplasms 8Thyroid Neoplasms 6Thyroid Carcinoma, Anaplastic 5Pheochromocytoma 5Neoplasms 4Paraganglioma 3Multiple Endocrine Neoplasia Type 1 3Small Cell Lung Carcinoma 2Recurrence 2Rectal Neuroendocrine Tumor 2Pituitary ACTH Hypersecretion 2Neoplasm Metastasis 2Melanoma 2Cushing Syndrome 2Adenocarcinoma, Follicular 2Acromegaly 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Thyroid cancer, medullary 1Testicular Neoplasms 1Serotonin Syndrome 1Sarcoma 1SDH-Related Familial Paraganglioma 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatitis 1Prostatic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatitis × Endocrine × Clear all
NCT06822751 2026-02-17

FOMUTI

University Hospital, Rouen

Phase 3 Not yet recruiting
138 enrolled
Endocrine

Cystitis, Prostatitis, Urinary Tract Infections, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡